A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)

Age Related Macular Degeneration (AMD) Clinical Trial

Official title:
A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab

Status Completed

Clinical Trial Summary

This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in disease status.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Age Related Macular Degeneration (AMD)
Macular Degeneration

Clinical Trial Details

NCT number	NCT01542866
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	N/A
Start date	January 11, 2011
Completion date	November 30, 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02121353` - Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration	Phase 1/Phase 2
Active, not recruiting	`NCT03349801` - Development of Novel Clinical Endpoints in Intermediate AMD
Recruiting	`NCT05932069` - Active AMD Study to Improve Function in Veterans	N/A
Terminated	`NCT00327470` - An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD	Phase 4
Enrolling by invitation	`NCT05481827` - ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study	Phase 2
Completed	`NCT02464956` - Production of iPSC Derived RPE Cells for Transplantation in AMD